Inogen(US:INGN)2025-05-07 21:08Q1 2025 Financial Performance - Total revenue reached $82.3 million, a 5.5% increase year-over-year [4] - Total constant currency revenue was also $82.3 million, representing a 7.1% increase [4] - Net loss was $(6.174) million, an improvement compared to $(14.578) million in the same period last year [5] - Adjusted EBITDA (non-GAAP) was $36 thousand, a significant increase from $(7.642) million in the prior year [7] - Adjusted net loss was $(2.888) million, compared to $(10.422) million in the prior year [9] Revenue Breakdown by Category - Business-to-business domestic sales contributed $21.5 million, a 29.9% increase, representing 26.1% of total revenue [4] - Business-to-business international sales amounted to $32.0 million, a 22.9% increase, accounting for 38.9% of total revenue [4] - Direct-to-consumer domestic sales were $15.0 million, a decrease of 26.8%, making up 18.2% of total revenue [4] - Rental revenue was $13.8 million, a decrease of 7.5%, representing 16.8% of total revenue [4] Operating Expenses - Total operating expenses were $44.028 million, a decrease from $50.645 million in the prior year [5] - Research and development expenses decreased to $4.034 million from $6.578 million [5] - Sales and marketing expenses decreased to $23.757 million from $26.936 million [5] - General and administrative expenses decreased to $16.237 million from $17.131 million [5]